203 completed, 91 recruiting, 59 unknown, 52 terminated. 470 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 470 | Completed 203, Recruiting 91, Unknown 59, Terminated 52, Not yet recruiting 29, Active not recruiting 16, Withdrawn 14, Enrolling by invitation 3, Suspended 3 |
Follow Hemostatic Disorders: new trials by email Literature Review of Hemostatic Disorders trials Research Report on Hemostatic Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MM-CARE: Cardiovascular Risk Assessment in Adults With Multiple Myeloma Oncology-Embedded Cardiovascular Risk Assessment Pathway, Primary Care Provider-Directed Cardiovascular Risk Assessment Pathway - Multiple Myeloma, Heart Disease Risk Factors | Not applicable | Not yet recruiting | University of Vermont Medical Center | 33 | 2028-02-01 | 2026-08-25 |
| The Feasibility and Effects of Exercise on Patients Suffering From Multiple Myeloma Individual Exercise, Group Exercise - Multiple Myeloma | Not applicable | Suspended | Medical University of Vienna | 45 | 2027-09-01 | 2026-10-09 |
| An Exercise and Lifestyle Programme for Adults With Vascular Ehlers-Danlos Syndrome: A Feasibility Study Co-designed exercise-based lifestyle intervention - Vascular Ehlers Danlos Syndrome | Not applicable | Not yet recruiting | Sheffield Hallam University | 40 | 2027-03-01 | 2026-07-13 |
| Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS) mHealth Intervention - Lung Cancer, Breast Cancer | Not applicable | Suspended | Ohio State University Comprehensive Cancer Center | 120 | 2026-11-15 | 2026-08-17 |
| Evaluation of the Role of Serum Tenascin-X Levels in the Diagnosis of Hypermobile Ehlers-Danlos Syndrome Blood sampling - Ehlers-Danlos Syndromes (EDS) | Not applicable | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 80 | 2026-11-01 | 2026-10-27 |
| Monitoring for CardioToxicity Using WeArable deVices While Undergoing cancEr Treatments (MCT-WAVE) Mobile Cardiac Telemetry, Wearable Cardiac Monitor - Cardiotoxicity, Cancer | Not applicable | Not yet recruiting | University of Minnesota | 72 | 2026-10-29 | 2026-10-06 |
| Prospective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE® Infusion System Subcutaneous Daratumumab Administration Using FreedomEDGE® - Multiple Myeloma or Amyloidosis | Not applicable | Not yet recruiting | Hospices Civils de Lyon | 100 | 2026-10-01 | 2026-07-23 |
| Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging ¹⁸F-florbetaben - Monoclonal Gammopathy, Monoclonal Gammopathy of Undetermined Significance (MGUS) | Not applicable | Not yet recruiting | University of Zurich | 50 | 2026-10-01 | 2026-06-03 |
| COG+OT Telerehabilitation for Adults With Subjective Cognitive Complaints COG+OT Telerehabilitation - Subjective Cognitive Complaints, Ehlers-Danlos Syndrome | Not applicable | Not yet recruiting | Medical University of South Carolina | 16 | 2026-10-01 | 2026-09-21 |
| Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention Gustabor server, Standard Recommendations - Multiple Myeloma (MM), GI Cancer | Not applicable | Recruiting | Wuerzburg University Hospital | 198 | 2026-07-24 | 2026-08-20 |
| STABLE Pilates for Hypermobility Pilates, Education - Ehlers-Danlos Syndrome (EDS), Hypermobile EDS (hEDS) | Not applicable | Recruiting | Brigham and Women's Hospital | 100 | 2026-07-09 | 2026-08-19 |
| CD38 Targeted -PET/ CT for Multiple Myeloma standard-of-care imaging (FDG PET/CT), CD38 PET/CT - Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma | Not applicable | Recruiting | Guilin Medical University, China | 100 | 2026-07-07 | 2026-08-24 |
| Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors Connected home blood pressure monitoring with daily IPA supervision. - Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma ( FL) | Not applicable | Not yet recruiting | Centre Hospitalier de la côte Basque | 40 | 2026-07-01 | 2026-06-22 |
| PET-Enabled Dual-Energy CT in Multiple Myeloma PET-enabled dual-energy CT imaging, X-ray dual-energy CT imaging - Multiple Myeloma (MM) | Not applicable | Not yet recruiting | University of California, Davis | 45 | 2026-07-01 | 2026-06-15 |
| Effect of ACTIVE-Care on Cancer-Related Fatigue, Hope, and Psychological Resilience in Adolescents With Acute Lymphoblastic Leukemia ACTIVE-Care Integrated Physical Activity-Based Supportive Care Program - Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Adolescent | Not applicable | Completed | Selcuk University | 70 | 2026-07-01 | 2026-10-20 |
| Biological Collection of the Rare Diseases of the Brain and Eye Vessels Cohort - 2 Biocollection, Neurological evaluation and Biocollection - CADASIL, Cavernous Angioma | Not applicable | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 600 | 2026-06-30 | 2026-06-16 |
| Immune Fitness in Older Patients With Relapsed and Refractory Multiple Myeloma immunophenotyping of lymphocyte - Myeloma Multiple | Not applicable | Recruiting | Jules Bordet Institute | 31 | 2026-06-03 | 2026-06-29 |
| Hamstring Strengthening in Hypermobile Conditions Progressive resistance exercise with an emphasis on eccentric hamstring loading. - Hypermobile EDS (hEDS), Hypermobile Ehlers-Danlos Syndrome | Not applicable | Not yet recruiting | University of Calgary | 20 | 2026-06-01 | 2026-06-04 |
| Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event TempTraq, VitalTraq - Cytokine Release Syndrome, Neoplasms | Not applicable | Enrolling by invitation | National Cancer Institute (NCI) | 136 | 2026-05-27 | 2026-06-25 |
| A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma Biospecimen Collection, Cognitive Intervention, Electronic Health Record Review - Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Multiple Myeloma | Not applicable | Recruiting | Ohio State University Comprehensive Cancer Center | 90 | 2026-04-28 | 2026-05-27 |
Showing 20 of 470. Sign in to see all of them.
Multiple Myeloma (335) · Lymphoma (81) · Lymphoma, Non-Hodgkin (67) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (67) · Leukemia, Lymphocytic, Chronic, B-Cell (64) · Hodgkin Disease (63) · Leukemia (55) · Lymphoma, Mantle-Cell (52) · Lymphoma, Follicular (50) · Leukemia, Myeloid, Acute (48) · Lymphoma, Large B-Cell, Diffuse (47) · Lymphoma, B-Cell, Marginal Zone (46) · Burkitt Lymphoma (44) · Neoplasms (43)
Cardiovascular Diseases (470) · Hemic and Lymphatic Diseases (470) · Hemorrhagic Disorders (470) · Vascular Diseases (470) · Hematologic Diseases (464) · Immune System Diseases (359) · Neoplasms by Histologic Type (352) · Blood Protein Disorders (349) · Immunoproliferative Disorders (349) · Paraproteinemias (346) · Lymphoproliferative Disorders (342) · Neoplasms, Plasma Cell (316) · Neoplasms (311) · Pathological Conditions, Signs and Symptoms (155)
Cyclophosphamide (20) · Blood Specimen Collection (15) · Peripheral Blood Stem Cell Transplantation (14) · fludarabine phosphate (14) · Cyclosporine (13) · Exercise (12) · Antilymphocyte Serum (11) · Whole-Body Irradiation (11) · Busulfan (9) · Filgrastim (9) · Melphalan (9) · Mycophenolic Acid (9) · fludarabine (9) · Dexamethasone (8) · Etoposide (7)
Fred Hutchinson Cancer Center (11) · Hospices Civils de Lyon (10) · Assistance Publique - Hôpitaux de Paris (9) · M.D. Anderson Cancer Center (7) · Mayo Clinic (7) · Case Comprehensive Cancer Center (6) · Memorial Sloan Kettering Cancer Center (6) · Ohio State University Comprehensive Cancer Center (6) · Roswell Park Cancer Institute (6) · University Hospital, Angers (6) · University of California, San Francisco (6) · Centre Hospitalier Universitaire, Amiens (5) · Dana-Farber Cancer Institute (5) · Imperial College London (5) · Massachusetts General Hospital (5)
United States (215) · France (65) · China (47) · Canada (16) · Germany (16) · Italy (12) · United Kingdom (11) · Belgium (9) · Denmark (9) · Netherlands (9) · Spain (6) · South Korea (5) · Taiwan (5) · Turkey (Türkiye) (5) · Austria (4)
Rahul Banerjee, MD (4) · Claire L Shovlin, PhD FRCP (3) · Jens Hillengass (3) · Ann Woolfrey (2) · Charles A. Linker, MD (2) · Claudio Brunstein, MD (2) · David Maloney (2) · Fuling Zhou (2) · Gustavo Plaza-Manzano, PhD (2) · Michael J. Fisch, MD, MPH, FACP (2) · Nadine H. Abdallah, MD (2) · Paul Martin (2) · Urvi A Shah, MD, MS (2) · Weiping Tan, PhD (2) · Wenming Chen, doctor (2)
PMID 32499241, PMID 24146883, PMID 33031789, PMID 34794687, PMID 36853224, PMID 11961015, PMID 15894595, PMID 16330788, PMID 18304416, PMID 18698002, PMID 19094458, PMID 19922917, PMID 19936413, PMID 20505654, PMID 20814774, PMID 20952514, PMID 21194248, PMID 21715313, PMID 21719601, PMID 21976674, PMID 22196464, PMID 22816680, PMID 23046417, PMID 23065508, PMID 23358983, PMID 23404156, PMID 23445111, PMID 23524640, PMID 24125911, PMID 24239343, PMID 24277820, PMID 24354965, PMID 24458873, PMID 24676541, PMID 24686867, PMID 24760791, PMID 24969777, PMID 25595400, PMID 25753814, PMID 25809519, PMID 25880761, PMID 26586530, PMID 26869630, PMID 27025228, PMID 27107394, PMID 27116331, PMID 27195194, PMID 27263447, PMID 27727478, PMID 27730189
P30CA015704 (5), P30CA033572 (4), P30CA043703 (3), P30CA138292 (3), 2019 (2), 4UL1TR000427-10 (2), K01AT010488 (2), P01CA018029 (2), P30CA014520 (2), P30CA016672 (2), P30CA022453 (2), U2CCA252981 (2), UG1CA189823 (2), 1OT2OD028183-01 (1), 2009 (1)